- H J M Vrijhoef, research fellowa (b.vrijhoef@zw.unimaas.nl),
- C Spreeuwenberg, professora,
- I M J G Eijkelberg, research fellowb,
- B H R Wolffenbuttel, associate professorc,
- G G van Merode, associate professorb
- a Department of Health Care Studies, Faculty of Health Sciences, University of Maastricht, PO Box 616, 6200 MD Maastricht, Netherlands
- b Department of Health Organisation, Policy and Economics, Faculty of Health Sciences, University of Maastricht, PO Box 616, 6200 MD Maastricht, Netherlands
- c Department of Endocrinology, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, Netherlands
- Correspondence to: H J M Vrijhoef
- Accepted 5 September 2001
Chronic diseases and associated conditions will always pose a challenge to healthcare systems. New healthcare models are being introduced in Western countries in response to a set of problems that are evident to some degree in all health services—for example, uncoordinated arrangements for delivering care, bias towards acute treatment, neglect of preventive care, and inappropriate treatment.1 These models take account of the pressure on quality and costs of chronic care and originate from the overlapping approaches of integrated care (United States) and shared care (western Europe). 2 3 In the Netherlands, shared care models have acted as a precursor of the recently introduced concept of disease management. Although several disease management initiatives are emerging, the model is not being adopted as fast as might be expected from the benefits that are claimed to result from it.4 In this article we describe the process of moving from a shared care model to a disease management model by considering recent developments in diabetes care in the region of Maastricht. We also describe the use of health technology assessment to evaluate the model.
Summary points
The concepts of integrated care and shared care can be regarded, in the Netherlands at least, as the precursor of disease management
Implementation of a shared care model for diabetes in the region of Maastricht ensured that necessary conditions were met for a disease management model
Widespread use of disease management models is hampered by lack of evidence
Evidence from health technology assessment is necessary to justify large scale use of disease management models but will not be sufficient by itself
Shared diabetes care in Maastricht region
Shared care for patients with stable diabetes mellitus type 2 who were receiving care from an endocrinologist in an outpatient clinic was implemented in the region of Maastricht in 1997. Two changes were made from usual care: …
Sign in
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record







CiteULike
Connotea
Del.icio.us
Digg
Facebook
Mendeley
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
Re: Transforming translation
Published 30 May 2012
Re: Bringing Nightingale down to size
Published 29 May 2012
Re: Avoid antimuscarinic drugs in people with dementia
Published 29 May 2012
Re: Strengthening primary health care: Related to the integration of medical training, community service need and health administration
Published 29 May 2012
Re: Strengthening primary health care: Related to the integration of medical training, community service need and health administration
Published 29 May 2012
Most responses
Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10 (12 responses)
Published 10 May 2012 - 23:32
The psychiatric oligarchs who medicalise normality (9 responses)
Published 2 May 2012 - 15:42
Are doctors justified in taking industrial action in defence of their pensions? No (8 responses)
Published 8 May 2012 - 12:21
Are doctors justified in taking industrial action in defence of their pensions? Yes (8 responses)
Published 8 May 2012 - 12:21
The hardest thing: admitting error (7 responses)
Published 2 May 2012 - 12:27